Healthy Living/WellnessAstraZeneca To Pay Inovio $727.5 Million For Experimental Cancer Drug AstraZeneca has agreed to pay Inovio $27.5 million up front and as much as $700 million once the latter's INO-3112 immunotherapy reaches certain developments and commercial milestones.by Rhodi Lee
Will Apple Launch a 32‑Inch iMac? 32‑Inch iMac Rumors, Apple Display Size Leaks, and Bold iMac 2026 Predictions